Literature DB >> 32798217

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays.

Edward I Patterson1, Tessa Prince2, Enyia R Anderson1, Aitor Casas-Sanchez1, Shirley L Smith3, Cintia Cansado-Utrilla1, Tom Solomon2,4, Michael J Griffiths2,5,6, Álvaro Acosta-Serrano1, Lance Turtle2,7, Grant L Hughes1.   

Abstract

The scientific community has responded to the coronavirus disease 2019 (COVID-19) pandemic by rapidly undertaking research to find effective strategies to reduce the burden of this disease. Encouragingly, researchers from a diverse array of fields are collectively working towards this goal. Research with infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is undertaken in high-containment laboratories; however, it is often desirable to work with samples at lower-containment levels. To facilitate the transfer of infectious samples from high-containment laboratories, we have tested methods commonly used to inactivate virus and prepare the sample for additional experiments. Incubation at 80°C, a range of detergents, Trizol reagents, and UV energies were successful at inactivating a high titer of SARS-CoV-2. Methanol and paraformaldehyde incubation of infected cells also inactivated the virus. These protocols can provide a framework for in-house inactivation of SARS-CoV-2 in other laboratories, ensuring the safe use of samples in lower-containment levels.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  SARS-Cov-2; Trizol; detergents; inactivation; methanol; paraformaldehyde; temperature

Mesh:

Substances:

Year:  2020        PMID: 32798217      PMCID: PMC7529010          DOI: 10.1093/infdis/jiaa507

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Virus inactivation and protein recovery in a novel ultraviolet-C reactor.

Authors:  J Wang; A Mauser; S-F Chao; K Remington; R Treckmann; K Kaiser; D Pifat; J Hotta
Journal:  Vox Sang       Date:  2004-05       Impact factor: 2.144

2.  Evaluation of the inactivation of Venezuelan equine encephalitis virus by several common methods.

Authors:  Edward I Patterson; Kelsey L Warmbrod; Donald H Bouyer; Naomi L Forrester
Journal:  J Virol Methods       Date:  2018-04       Impact factor: 2.014

Review 3.  Antigen retrieval immunohistochemistry: past, present, and future.

Authors:  S R Shi; R J Cote; C R Taylor
Journal:  J Histochem Cytochem       Date:  1997-03       Impact factor: 2.479

4.  Thermal stability and inactivation of hepatitis C virus grown in cell culture.

Authors:  Hongshuo Song; Jin Li; Shuang Shi; Ling Yan; Hui Zhuang; Kui Li
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

7.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

8.  Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.

Authors:  Miriam E R Darnell; Kanta Subbarao; Stephen M Feinstone; Deborah R Taylor
Journal:  J Virol Methods       Date:  2004-10       Impact factor: 2.014

9.  Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.

Authors:  Yang Pan; Luyao Long; Daitao Zhang; Tingting Yuan; Shujuan Cui; Peng Yang; Quanyi Wang; Simei Ren
Journal:  Clin Chem       Date:  2020-06-01       Impact factor: 8.327

10.  Stability and inactivation of SARS coronavirus.

Authors:  H F Rabenau; J Cinatl; B Morgenstern; G Bauer; W Preiser; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

View more
  71 in total

1.  Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy.

Authors:  E I Patterson; G Elia; A Grassi; A Giordano; C Desario; M Medardo; S L Smith; E R Anderson; T Prince; G T Patterson; E Lorusso; M S Lucente; G Lanave; S Lauzi; U Bonfanti; A Stranieri; V Martella; F Solari Basano; V R Barrs; A D Radford; U Agrimi; G L Hughes; S Paltrinieri; N Decaro
Journal:  Nat Commun       Date:  2020-12-04       Impact factor: 14.919

2.  Propagation and Quantification of SARS-CoV-2.

Authors:  Alexander S Jureka; Christopher F Basler
Journal:  Methods Mol Biol       Date:  2022

3.  Inhibition of Protein N-Glycosylation Blocks SARS-CoV-2 Infection.

Authors:  Aitor Casas-Sanchez; Alessandra Romero-Ramirez; Eleanor Hargreaves; Cameron C Ellis; Brian I Grajeda; Igor L Estevao; Edward I Patterson; Grant L Hughes; Igor C Almeida; Tobias Zech; Álvaro Acosta-Serrano
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

4.  Inactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant.

Authors:  Enyia R Anderson; Grant L Hughes; Edward I Patterson
Journal:  Access Microbiol       Date:  2021-04-26

5.  SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay.

Authors:  Michael D Buck; Enzo Z Poirier; Ana Cardoso; Bruno Frederico; Johnathan Canton; Sam Barrell; Rupert Beale; Richard Byrne; Simon Caidan; Margaret Crawford; Laura Cubitt; Sonia Gandhi; Robert Goldstone; Paul R Grant; Kiran Gulati; Steve Hindmarsh; Michael Howell; Michael Hubank; Rachael Instrell; Ming Jiang; George Kassiotis; Wei-Ting Lu; James I MacRae; Iana Martini; Davin Miller; David Moore; Eleni Nastouli; Jerome Nicod; Luke Nightingale; Jessica Olsen; Amin Oomatia; Nicola O'Reilly; Anett Rideg; Ok-Ryul Song; Amy Strange; Charles Swanton; Samra Turajlic; Mary Wu; Caetano Reis e Sousa
Journal:  Wellcome Open Res       Date:  2021-05-21

Review 6.  Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.

Authors:  Fouad A Abolaban; Fathi M Djouider
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

7.  Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt.

Authors:  Amani A Saleh; Mohamed A Saad; Islam Ryan; Magdy Amin; Mohamed I Shindy; Wael A Hassan; Mahmoud Samir; Ayman A Khattab; Sherein S Abdelgayed; Mohamed G Seadawy; Hossam M Fahmy; Khaled Amer
Journal:  Antib Ther       Date:  2021-06-25

8.  Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.

Authors:  S Ulloa; C Bravo; E Ramirez; R Fasce; J Fernandez
Journal:  J Virol Methods       Date:  2021-06-22       Impact factor: 2.623

9.  Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva.

Authors:  Thomas J Ketas; Devidas Chaturbhuj; Victor M Cruz Portillo; Erik Francomano; Encouse Golden; Sharanya Chandrasekhar; Gargi Debnath; Randy Díaz-Tapia; Anila Yasmeen; Kyle D Kramer; Tarek Munawar; Wilhelm Leconet; Zhen Zhao; Philip J M Brouwer; Melissa M Cushing; Rogier W Sanders; Albert Cupo; Per Johan Klasse; Silvia C Formenti; John P Moore
Journal:  Pathog Immun       Date:  2021-06-07

10.  Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.

Authors:  Graham J Britton; Alice Chen-Liaw; Francesca Cossarini; Alexandra E Livanos; Matthew P Spindler; Tamar Plitt; Joseph Eggers; Ilaria Mogno; Ana S Gonzalez-Reiche; Sophia Siu; Michael Tankelevich; Lauren Tal Grinspan; Rebekah E Dixon; Divya Jha; Adriana van de Guchte; Zenab Khan; Gustavo Martinez-Delgado; Fatima Amanat; Daisy A Hoagland; Benjamin R tenOever; Marla C Dubinsky; Miriam Merad; Harm van Bakel; Florian Krammer; Gerold Bongers; Saurabh Mehandru; Jeremiah J Faith
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.